Considering taking medication to treat heterozygous familial hypercholesterolemia?

Below is a list of common medications used to treat or reduce the symptoms of heterozygous familial hypercholesterolemia. Follow the links to read common uses, side effects, dosage details and read user reviews for the drugs listed below.

67 medications found for ‘heterozygous familial hypercholesterolemia’

Drug Name

Label

Type

User Reviews

Reviews

advicor 500 mg-20 mg tablet,extended releaseOn LabelRXReviews
alirocumab syringeOn LabelRXReviews
altocor tablet, extended release 24 hrOn LabelRXReviews
altoprevOn LabelRXReviews
amlodipine-atorvastatinOn LabelRXReviews
antaraOn LabelRXReviews
atorvastatin calciumOn LabelRXReviews
bempedoic acid 180 mg tabletOn LabelRXReviews
bempedoic acid 180 mg-ezetimibe 10 mg tabletOn LabelRXReviews
caduetOn LabelRXReviews
colesevelam hclOn LabelRXReviews
crestorOn LabelRXReviews
evolocumab wearable injectorOn LabelRXReviews
ezallor sprinkle 40 mg capsule antihyperlipidemics hmgco-a reductase inhibitors (statins)On LabelRXReviews
ezetimibeOn LabelRXReviews
ezetimibe 10 mg-rosuvastatin 40 mg tablet selective cholesterol absorption inhibitorOff LabelRXReviews
ezetimibe-atorvastatin tabletRXReviews
ezetimibe-simvastatin tabletOn LabelRXReviews
fenofibrateOn LabelRXReviews
fenofibrate capsuleOn LabelRXReviews
fenofibrate capsuleOn LabelRXReviews
fenofibrate tabletOn LabelRXReviews
fenofibric acidOn LabelRXReviews
fenofibric acid capsule,delayed release (enteric coated)On LabelRXReviews
fenoglideOn LabelRXReviews
fibricorOn LabelRXReviews
flolipidOn LabelRXReviews
fluvastatin erOn LabelRXReviews
fluvastatin sodiumOn LabelRXReviews
inclisiran 284 mg/1.5 ml subcutaneous syringeRXReviews
juvisync tabletRXReviews
leqvio 284 mg/1.5 ml subcutaneous syringe antihyperlipidemic - pcsk9 inhibitorsRXReviews
lescolOn LabelRXReviews
lescol xlOn LabelRXReviews
lipitorOn LabelRXReviews
lipofenOn LabelRXReviews
liptruzet tabletRXReviews
lofibra 67 mg capsuleOn LabelRXReviews
lovastatinOn LabelRXReviews
lovastatin tablet, extended release 24 hrOn LabelRXReviews
mevacorOn LabelRXReviews
nexletol 180 mg tablet antihyperlipidemic - atp-citrate lyase (acly) inhibitorOn LabelRXReviews
nexlizet 180 mg-10 mg tablet selective cholesterol absorption inhibitorOn LabelRXReviews
niacin er 500 mg-lovastatin 20 mg tablet,extended release 24h mphaseOn LabelRXReviews
niacin-simvastatin tablet, extended release multiphase 24 hr (tablet, er hr)Off LabelRXReviews
praluent pen injectorOn LabelRXReviews
praluent syringe 75 mg/ml subcutaneousOn LabelRXReviews
pravacholOn LabelRXReviews
pravastatin sodiumOn LabelRXReviews
repatha pushtronex 420 mg/3.5 ml subcutaneous wearable injector antihyperlipidemic - pcsk9 inhibitorsOn LabelRXReviews
repatha sureclick 140 mg/ml subcutaneous pen injector antihyperlipidemic - pcsk9 inhibitorsOn LabelRXReviews
repatha syringe 140 mg/ml subcutaneous antihyperlipidemic - pcsk9 inhibitorsOn LabelRXReviews
rosuvastatin calciumOn LabelRXReviews
roszet 10 mg-40 mg tablet selective cholesterol absorption inhibitorOff LabelRXReviews
simcor tablet, extended release multiphase 24 hr (tablet, er hr)Off LabelRXReviews
simvastatinOn LabelRXReviews
sitagliptin-simvastatin tabletRXReviews
tricorOn LabelRXReviews
triglideOn LabelRXReviews
trilipixOn LabelRXReviews
vytorinOn LabelRXReviews
vytorin 10 mg-40 mg tabletOn LabelRXReviews
vytorin 10 mg-80 mg tabletOn LabelRXReviews
vytorin tabletOn LabelRXReviews
welchol 625 mg tabletOn LabelRXReviews
zetiaOn LabelRXReviews
zocorOn LabelRXReviews

The display and use of drug information on this site is subject to express terms of use. By continuing to view the drug information, you agree to abide by such terms of use.